26081-03-8 Usage
Description
(R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE, also known as (R)-JQ1, is a chemical compound that has demonstrated potential as a therapeutic agent for the treatment of various cancers and diseases. It is a potent and selective inhibitor of the BET family of bromodomain-containing proteins, which play a crucial role in the regulation of gene expression. (R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE has been studied for its ability to inhibit the growth of cancer cells, particularly in leukemia, lymphoma, and solid tumors, as well as for its potential in treating certain inflammatory and autoimmune diseases. As a result, (R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE has emerged as a promising candidate for the development of novel therapeutic interventions.
Uses
Used in Oncology:
(R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE is used as an anticancer agent for its ability to inhibit the growth of cancer cells, particularly in leukemia, lymphoma, and solid tumors. It targets the BET family of bromodomain-containing proteins, which are involved in the regulation of gene expression, and disrupts the processes that contribute to cancer cell proliferation and survival.
Used in the Treatment of Inflammatory and Autoimmune Diseases:
(R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE is used as a potential treatment for certain inflammatory and autoimmune diseases due to its ability to modulate the activity of the BET family of proteins. By targeting these proteins, it may help in controlling inflammation and immune responses associated with these conditions.
Used in Drug Development:
(R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE is used as a promising candidate for the development of novel therapeutic interventions in various medical fields. Its potential as a therapeutic agent in the treatment of cancers and diseases has garnered interest among researchers and pharmaceutical companies, leading to further studies and exploration of its applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 26081-03-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,8 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 26081-03:
(7*2)+(6*6)+(5*0)+(4*8)+(3*1)+(2*0)+(1*3)=88
88 % 10 = 8
So 26081-03-8 is a valid CAS Registry Number.
26081-03-8Relevant articles and documents
Protecting-Group-Free Amidation of Amino Acids using Lewis Acid Catalysts
Sabatini, Marco T.,Karaluka, Valerija,Lanigan, Rachel M.,Boulton, Lee T.,Badland, Matthew,Sheppard, Tom D.
supporting information, p. 7033 - 7043 (2018/05/04)
Amidation of unprotected amino acids has been investigated using a variety of ‘classical“ coupling reagents, stoichiometric or catalytic group(IV) metal salts, and boron Lewis acids. The scope of the reaction was explored through the attempted synthesis of amides derived from twenty natural, and several unnatural, amino acids, as well as a wide selection of primary and secondary amines. The study also examines the synthesis of medicinally relevant compounds, and the scalability of this direct amidation approach. Finally, we provide insight into the chemoselectivity observed in these reactions.
ANTI-INFLAMMATORY AGENTS
-
Page/Page column 16, (2010/02/11)
The invention relates to the use of 3-aminocaprolactam derivatives for preparing a medicament intended to prevent or treat inflammatory disorders, and uses compounds of general formula (I) or a pharmaceutically acceptable salts thereof; wherein X is -CO-R1 or-S02-R2, and R1 and R2 are carbonaceous substituents.
CATALYTIC ASYMMETRIC SYNTHESIS OF L-LYSINE
Klabunovskii, E. I.,Karpeiskaya, E. I.,Levitina, E. S.,Godunova, L. F.,Kaigorodova, L. N.
, p. 1996 (2007/10/02)
-
